The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium (2S)-2-((S)-3-cyclohexyl-2-undecanamidopropanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonate ID: ALA4093269
PubChem CID: 137655624
Max Phase: Preclinical
Molecular Formula: C27H48N3NaO8S
Molecular Weight: 575.77
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCOC(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(O)S(=O)(=O)[O-].[Na+]
Standard InChI: InChI=1S/C27H49N3O8S.Na/c1-2-3-4-5-6-7-8-12-17-38-27(34)30-22(18-20-13-10-9-11-14-20)25(32)29-23(26(33)39(35,36)37)19-21-15-16-28-24(21)31;/h20-23,26,33H,2-19H2,1H3,(H,28,31)(H,29,32)(H,30,34)(H,35,36,37);/q;+1/p-1/t21-,22-,23-,26?;/m0./s1
Standard InChI Key: AOGCBPAFUQGITD-XPPLUXQBSA-M
Molfile:
RDKit 2D
41 41 0 0 0 0 0 0 0 0999 V2000
28.9181 -20.2672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8652 -18.7993 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.4273 -16.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2816 -17.5801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4519 -19.4974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7182 -15.9579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4273 -17.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8770 -21.2960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3361 -21.5014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0048 -21.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5613 -18.7781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4273 -19.6126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9909 -19.6127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2817 -18.3952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9906 -17.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5857 -18.3966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8409 -19.3737 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
29.1469 -18.3949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9905 -16.3624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2758 -19.4972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4275 -18.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6612 -21.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7184 -18.3951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7183 -17.5799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9908 -18.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7499 -20.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8536 -18.3669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1445 -18.7732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8562 -17.5497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.4427 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7369 -18.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0311 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3254 -18.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6196 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9139 -18.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2081 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5024 -18.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7966 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0909 -18.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1453 -17.5777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5781 -16.1792 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
2 16 1 0
25 23 1 0
4 15 1 0
1 12 1 6
9 22 1 0
19 6 1 0
15 19 1 0
14 11 1 0
2 20 2 0
6 3 1 0
26 10 1 0
23 21 1 0
22 1 1 0
1 26 1 0
18 2 1 0
7 24 1 0
25 14 1 0
9 10 1 0
21 18 1 0
22 8 2 0
14 4 1 1
3 7 1 0
5 2 2 0
21 17 1 1
21 12 1 0
25 13 2 0
15 24 1 0
11 27 1 0
27 28 1 0
27 29 2 0
28 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
18 40 1 0
M CHG 2 16 -1 41 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 575.77Molecular Weight (Monoisotopic): 575.3240AlogP: 3.41#Rotatable Bonds: 18Polar Surface Area: 171.13Molecular Species: ACIDHBA: 7HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: -1.14CX Basic pKa: ┄CX LogP: 2.51CX LogD: 1.30Aromatic Rings: ┄Heavy Atoms: 39QED Weighted: 0.12Np Likeness Score: 0.35
References 1. Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Damalanka VC, Weerawarna PM, Doyle ST, Alsoudi AF, Dissanayake DMP, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.. (2017) Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors., 126 [PMID:27914364 ] [10.1016/j.ejmech.2016.11.027 ]